For example, in pediatric patients with primary hypertension, elevated sclerostin levels are linked with lower systolic blood pressure, whereas in postmenopausal women with nonobstructive CAD, higher sclerostin levels help preserve coronary function despite vascular changes [38,39]. This evidence concerns the gene SOST and essential hypertension.